The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009

Trop Med Int Health. 2012 Aug;17(8):e66-73. doi: 10.1111/j.1365-3156.2012.02841.x.

Abstract

Objective: To investigate trends in all-cause adult mortality after the roll-out of an antiretroviral therapy (ART) programme in rural Uganda.

Methods: Longitudinal population-based cohort study of approximately 20,000 residents in rural Uganda. Mortality in adults aged 15-59 years was determined for the 5-year period (1999-2003) before introduction of ART in January 2004 and for the 5-year period afterwards. Poisson regression was used to estimate mortality rate ratios (RRs) for the period before ART, 1 year after ART introduction (from January 2004 to January 2005) and more than 1 year after ART introduction. Trends in mortality were analysed by HIV status, age and sex.

Results: Before ART became available, the mortality rate (deaths per 1000 person-years) was 4.0 (95% CI = 3.3-4.8) among HIV-negative individuals and 116.4 (95% CI = 101.9-133.0) among HIV-positive individuals. During the period January 2004-end November 2009, 279 individuals accessed ART. In the year after ART was introduced, the mortality rate (deaths per 1000 person-years) among HIV-negative individuals did not change significantly (adjusted RR = 0.95, 95% CI = 0.61-1.47), but among HIV-positive individuals dropped by 25% to 87.4 (adjusted RR = 0.75, 95% CI = 0.53-1.06). In the period 2005-2009, the mortality rate (deaths per 1000 person-years) among HIV-positive individuals fell further to 39.9 (adjusted RR = 0.33, 95% CI = 0.26-0.43). The effect was greatest among individuals aged 30-44 years, and trends were similar in men and women.

Conclusion: The substantially reduced mortality rate among HIV-positive individuals after ART roll-out lends further support to the intensification of efforts to ensure universal access to ART.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Anti-Retroviral Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Counseling
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / mortality*
  • HIV Seropositivity / drug therapy
  • HIV Seropositivity / mortality
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mortality / trends
  • Rural Population / statistics & numerical data*
  • Sex Distribution
  • Uganda / epidemiology
  • Young Adult

Substances

  • Anti-Retroviral Agents